look leverag better organ growth
depend market condit commentari compani
confer call dial-in expect stock
okay report revenu ep compar
cse/st amid organ growth
increment margin rel cse/st stock comp
elev due earnout continu invest press
margin underwhelm margin impress
organ revenu growth support stock
maintain ep increas revenu
lower margin increas tp ev/ebitda
maintain neutral recogn vrsk busi strength find
positivesorgan growth cse modest
stack acceler qoq addit
small encourag see argu revenu acceler
negativesmultipl item impact margin underwhelm
amid essenti flat yoy despit strong revenu growth
margin yoy
watch call dial-in monitor
commentari surround forward pace margin expans given
margin increment underwhelm though
recogn acceler stock compens impact quarter
tp prior equat ev/ebitda compar
rang averag risk includeenergi
soft underwhelm acquisit integr insur
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price jul rate neutral target price analyst kevin mcveigh
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
 close
scenario predic reacceler
organ growth expand margin drive ebitda
expect believ would warrant p/fcf
multipl ev/ebitda
grey scenario predic continu deceler
organ growth lower margin due leverag invest
spend drive underwhelm ebitda believ
would warrant p/fcf multipl ev/ebitda
verisk lead provid data analyt workflow solut
insur financi energi sector
compani mention price
